Screener
BioCryst Pharmaceuticals BCRX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
FAQ
- What is BioCryst Pharmaceuticals's total assets?
- BioCryst Pharmaceuticals (BCRX) reported total assets of $557.85M in Q2 2026.
- How has BioCryst Pharmaceuticals's total assets changed year-over-year?
- BioCryst Pharmaceuticals's total assets increased by 22.0% year-over-year, from $457.19M to $557.85M.
- What is the long-term trend for BioCryst Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's total assets has grown at a 9.0% compound annual growth rate (CAGR), from $334.72M to $514.16M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about BioCryst Pharmaceuticals's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude